Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Hong Kong Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20082
20091
20121
20141
20151
20161
20191
20201
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Recruiting2
Terminated2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
NRG Oncology2
AstraZeneca1
Chinese University of Hong Kong1
Exelixis1
Hoffmann-La Roche1
SFJ Pharma Ltd. II1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell18
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung5
Kidney Neoplasms5
Carcinoma4
Melanoma4
Neoplasm Metastasis4
Brain Neoplasms3
Lung Neoplasms3
Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.